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Abstract
Introduction. Primary cells in vitro culture scale-up is a crucial issue in cell-based tissue and organ regeneration 
therapy. Reducing costs and space occupied by the cells cultured in vitro has been an important target. Cells 
cultured in vitro with the use of bioreactor with dextran microcarriers (Cytodex®) have potentially a chance to 
meet many of the cell therapy requirements. 
Material and methods. We used collagen-coated carriers (Cytodex3®) and a spinner flask bioreactor to develop 
environment suitable for human myoblast proliferation. In parallel, standard adherent in vitro culture conditions 
for myoblasts propagation (T-flask) were conducted. Cell cycle characterization, senescence, myogenic gene ex-
pression and cell apoptosis were evaluated in order to find differences between two culture systems under study.
Results. The number of cells obtained in bioreactor per 106 of starting cells population was approximately ten 
times lower in comparison with T-flask culture system. The microcarriers cultured adult myoblasts in compari-
son with the regular T-flask culture showed faster and more advanced replicative aging and lower proliferative 
potential. Moreover, the percentage of the cells that entailed an irreversible cell arrest (G0 phase) was also 
significantly (p < 0.0001) increased. 
Conclusions. Our results suggest that population of primary human myoblasts obtained from adult individuals 
and propagated on dextran microcarriers did not meet the requirements of the regenerative medicine regard-
ing quantity and quality of the cells obtained. Nonetheless, further optimization of the cell scaling up process 
including both microcarriers and/or bioreactor program is still an important option. (Folia Histochem Cytobiol. 
2016, Vol. 54, No. 2, 81–90).
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Introduction
Cell populations prepared for the purpose of re-
generative medicine must meet the highest possible 
standards for both quantity and quality of transplant-
ed cells. Cell therapies are extremely promising in 
respect to many diseases, both inherited and acquired. 
Many cell types proposed as the source for potential 
cell replacement therapy, among them the mesenchy-
mal stem cells, embryonal stem cells (ESC) induced 
pluripotent stem cells (iPSC) and skeletal muscle stem 
cells, i.e. myoblasts, have been listed [1–4].
Satellite cells are located between the basal mem-
brane of skeletal muscle fibres and sarcolemma. In 
the case of injury or intense physical activity satellite 
cells are activated and subsequently proliferate to 
form new and/or fuse with already existing myocytes 
forming the new muscle fibres [5]. After isolation from 
muscle biopsy and during in vitro propagation, satel-
lite cells became activated and then they are named 
myoblasts. Myogenic origin of such myoblasts allows 
them to be potentially used to regenerate exhausted 
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skeletal muscle fibres in muscular dystrophies or to 
support infarcted myocardium as well as improve dys-
functional anal and/or bladder sphincters [6–9]. For 
over a decade preclinical and clinical trials were con-
ducted concerning the use of different types of stem 
cells; however, the obtained results did not meet the 
expectations, probably due to delivery of insufficient 
number of transplanted cells. Limited cell numbers 
obtained from a single donor patient and complexity 
of anchorage-dependent in vitro cell culture systems 
are among the unresolved issues. Number of myo-
blasts required for cell therapies are organ dependent 
and varies from 109 cells (treatment of ischaemic 
heart) to 1011 cells in muscular dystrophies [10, 11]. 
Such high number of myoblasts in T-flask in vitro 
culture (with density about 105 cells/cm2) requires 
an area approx. 10–100 m2. The organization of such 
a big in vitro myoblast culture system would present 
an enormous logistical task and extremely increase 
the costs of cell therapy [12].
Early data indicated that the use of Cytodex3® mi-
crocarriers in conjunction with the cell spinner biore-
actors could be the optimal solution for obtaining both 
significant cell numbers with less financial resources 
and better organization of in vitro culture labora-
tory. Collagen-coated dextran carriers (Cytodex3®) 
were tested with several cell types, i.e. hepatocytes, 
chondrocytes or mesenchymal stem cells and myo-
blasts [13]. Area offered by microcarriers is 2700 cm2 
for 1 g dry weight, thus relatively small amounts 
of beads and medium could be sufficient to obtain 
adequate surface to scale-up the adherent cells in 
in vitro culture.
The transplanted cell population should have 
the best possible characteristics because the in situ 
(recipient organ) conditions are usually sub-optimal 
and the ability of cells to anchor in the appropriate 
cell niche may greatly influence the therapy efficacy.
The aim of this study was to evaluate the prolif-
erative potential and percentage of cells with aging 
markers in human primary myoblasts in vitro cultures 
using both cell spinner bioreactor with Cytodex3® 
microcarriers and traditional T-flask culture system.
Material and methods
In vitro culture of myoblasts. Human satellite cells were 
isolated from skeletal muscle of adult persons obtained 
during the anterior cruciate ligament reconstruction as 
a post-operative medical waste and prepared as previously 
described [14]. For expansion, cells were cultured in parallel 
using standard T-flask (75 cm2) or with dextran microcarriers 
(GE-Amersham, Little Chalfont, UK) in the cell spinner 
flask — Cellspin (Integra, Plainsboro, NJ, USA). Carriers 
were prepared and sterilized according to the manufacturer’s 
recommendation, then they were introduced to the culture 
medium at a concentration of 3 g/L. T-flasks were used for 
cell propagation and maintenance until the cell numbers 
reached amount appropriate for designed experiments. 
Myoblasts were cultivated in DMEM medium (Lonza, Basel, 
Switzerland) with 20% FBS (foetal bovine serum), 2 mM 
alanyl-L-glutamine, 1% Pen/Strep/Amphotericin B (Lonza), 
1% Chick Embryo Extract (CEE, SeraLab, West Sussex, 
UK), and supplemented with fibroblast growth factor bFGF 
(Sigma-Aldrich, St. Louis, MO, USA). The in vitro culture 
was carried out in medium at 37°C and 5% CO2 concen-
tration, and the cells were kept in standard T-flasks. After 
obtaining the appropriate number of cells, myoblasts were 
inoculated to microcarriers resuspended in culture media in 
bioreactor (107 of cells per 100 mL, i.e. 12.5 × 104/cm2 Cy-
todex3® carrier surface). Then, agitation cycles started. The 
“adhesion” program included agitation cycle 20 rpm/5 min 
followed by 30 min rest cycle without agitation, subsequent 
“proliferation” program was based on continuous agitation 
with 30 rpm/min speed. Conventional (standard) in vitro cell 
culture with adherent cells was carried out simultaneously 
in order to make the appropriate comparisons. 
To confirm myogenic potential of obtained cell popula-
tions, cell samples were evaluated for desmin expression by 
immunocytochemistry and for CD56 surface marker by flow 
cytometry according to previously described protocols [15]. 
In order to identify the cell populations following abbrevia-
tions were used: (i) 2D-Myo-D0 (starting cell population), 
(ii) 2D-Myo-D14 (cell population obtained after 14 days 
of standard T-flask culture), and (iii) 3D-Myo-D14 (cell 
population obtained after 14 days of microcarrier culture).
Cell cycle analysis. Cells were centrifuged at 300 g, 10 min 
at room temperature. The pellets containing 106 cells were 
resuspended in 1 mL NIM-DAPI solution (Beckmann-Coul-
ter, Brea, CA, USA). Samples were incubated for 10 min on 
ice in the dark and then analysed in a flow cytometer (Cell 
Lab Quanta cytometer, Beckmann-Coulter).
Real-time PCR. RNA isolation was performed using 
TRI Reagent® Reagent (Sigma-Aldrich) according to 
manufacturer’s protocol. mRNA isolation was performed 
using magnetic Dynabeads® Oligo (dT) 25 (Thermofisher, 
Waltham, MA USA) and resuspended in 10.5 µL of 
DEPC-water. Then reverse transcription reaction was 
carried out. qRT-PCR for MYOG and ACTB (reference 
gene) was performed on 96-well plates. Single reaction 
volume sample was 25 µL and contained: 2 µL of cDNA, 
12.5 µL of 2× iQ™ SYBR® Green Supermix (BIO-RAD, 
USA) and 2.5 µL 4 µM of each primer. The reaction was 
performed using iCycler® IQ5 (BIO-RAD, Hercules, CA, 
USA) and SYBR Green dye. Primers used were as fol-
lowing: ACTB-F 5’-CTTCCTGGGCATGGAGTCC-3’; 
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OG-F 5’-GCTGTATGAGACATCCCCCTA-3’; MYOG-R 
5’ CGACTTCCTCTTACACACCTTAC-3’
Telomere length analysis. QIAamp DNA Mini Kit was 
used to isolate genomic DNA (Qiagen, Hilden, Germany). 
The analysis was performed using a telomere TeloTAGGG 
Length Assay (Roche, Basel, Switzerland). Enzymatic di-
gestion of genomic DNA with the HinfI and RsaI enzymes 
was carried out with subsequent electrophoretic separation 
of DNA fragments in 0.8% agarose gel. After denaturation 
and neutralization procedures, DNA overnight transfer 
with 20× SSC buffer to a nylon membrane was conducted. 
DNA was cross-linked through a two-minute exposure to 
UV light (l = 312 nm). Hybridization solution contained 
the specific DIG-labelled telomeric probe. Hybridization 
was carried out for 3 h at 42°C. Anti-DIG-AP was added 
for 30 min incubation. AP substrate CDP-star was applied 
to ensure chemiluminescence reaction and the membrane 
was exposed to X-ray film (GE-Amersham). The signal anal-
ysis used free ImageJ software (Wayne Rasband, National 
Institutes of Health, Bethesda, MD USA) to determine the 
mean TRF value (Terminal Restriction Fragment). This 
value was calculated with the formula:
where ODi value corresponds to the chemiluminescence 
signal and Li is length of TRF at i position. 
Cytochemical staining with SA-beta-galactosidase to assess 
cell aging. The procedure was performed using Cell Aging 
Senescence Detection Kit (BioVision, Milpitas, CA, USA). 
Passaged 3 × 105 myoblasts harvested at the time of analysis 
were seeded in a culture 6-well dish in the standard culture 
medium. Next, cells were cultured for 2 days, fixed in fixative 
solution (provided by manufacturer — BioVision, USA) 
and subjected to overnight incubation at 37°C in an X-Gal 
staining solution (Staining Solution Mix). Additionally, cells 
were counterstained with eosin and evaluated under the 
Olympus BX40 light microscope (Olympus, Tokyo, Japan). 
Three populations of cells were evaluated: I — negative for 
SA-b-Gal; II — moderately stained cells; III — cells with 
strong expression of SA-b-Gal. Free ImageJ software was 
used to analyse obtained data.
Immunofluorescence staining for Ki67 and H2A.X markers. 
Cells were fixed in 4% buffered formaldehyde solution. 
Cell membranes were permeabilized using 0.2% solution 
of Triton X-100. Non-specific epitopes blocking was per-
formed during incubation for 30 min in 10% goat serum, 
GS (Sigma-Aldrich). For the analysis polyclonal rabbit an-
ti-Ki67 (Abcam) and mouse anti-H2A.X (Abcam) diluted at 
1:500 in 10% GS were used. Both types of antibodies were 
incubated overnight in 4°C. For Ki67, a sheep anti-rabbit 
polyclonal TxRed-conjugated antibody was used (1:200; Ab-
cam) and for H2A.X we used a goat anti-mouse polyclonal 
FITC-conjugated antibody (1:4000; Abcam).The samples 
were counterstained with DAPI. Slides were observed and 
analysed under a fluorescence microscope Imager.D1 (Carl 
Zeiss, Jena, Germany). For H2A.X the number of foci per 
nucleus were counted and based on recognition of three 
cell population: negative for H2A.X; with less than 5 foci 
per nucleus (H2A.X < 5); with 5 or more than 5 foci per 
nucleus (H2A.X > 5). 
Apoptosis evaluation (Annexin V and PI staining). The anal-
ysis was performed using Annexin V-FITC Kit (Beckmann- 
Coulter) according to manufacturer’s recommendation. The 
cells were resuspended in the reaction mixture containing 
FITC-conjugated Annexin V and Propidium Iodide. Cell 
samples were incubated for 15 min on ice in the dark. After 
incubation, samples were evaluated on the Cell Lab Quanta 
cytometer (Beckmann-Coulter).
Statistical analysis. For all experiments statistical analyses 
were feasible and conducted in three replicates. The results 
were evaluated for normal distribution using Shapiro-Wilk 
test. In all cases data were calculated using ANNOVA 
together with Tukey multiple comparison post-tests and 
with p-value being adjusted for multiple comparisons. All 
the results (if not otherwise stated) are presented as mean 
± SEM.
Results
Comprehensive set of tests was developed to verify 
biological characteristics of primary human myoblast 
populations in two distinct in vitro cell culture systems 
tested. The obtained cell populations were assayed for 
telomere length, marker of cell aging (SA-b-galacto-
sidase) and the cell proliferation marker (Ki67). Also 
the presence of apoptotic cells was evaluated and the 
cell cycle analysis was performed. 
A diagram presenting in vitro cell propagation 
using both Cytodex3® (3D-Myo-D14) and T-flask 
(2D-Myo-D14) cultures is shown in Figure 1. Starting 
myoblast population (2D-Myo-D0) myogenic marker 
expression is depicted in Figure 2 presenting 71.7% of 
desmin positive cells and 63.3% cells positive for CD56.
Cells were allowed to adhere on Cytodex3® beads 
for about 3 hours. After this time, most of the cells 
were found to settle on dextran microcarriers and thus 
showed characteristic elongated shape (Figure 3A). 
We used a starting cell population of 2 × 106 myoblasts 
(2D-Myo-D0) and in 2 week culture we observed 
4.5 × 107 cells in standard T-flasks (2D-Myo-D14). On 
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the contrary, cells cultivated on microcarriers (with 
starting population 107) only doubled initial popula-
tion size (3D-Myo-D14 — 2.2 ×107 cells) (Figure 3B).
The cell cycle data showed that among the 
myoblasts cultured in spinner flask (3D-Myo-D14) 
there was a greater number of G0/G1 phase cells 
(p < 0.0001; Figure 4A) in contrast to the cells 
cultured in T-flask (2D-Myo-D14), which showed 
characteristics similar to the initial cell population. 
Telomere length analysis showed that culture 
systems (2D-Myo-D14 vs. 3D-Myo-D14) did not 
reveal any significant effect concerning telomere 
length, although as expected the telomere sequences 
underwent shortening during subsequent days of 
in vitro culture (Figure 4B). 
The evaluation of cell proliferation marker, 
Ki67 expression, showed that the number of 
proliferating cells was significantly decreased in 
both culture systems tested (17% positive cells in 
the starting population (2D-Myo-D0), 3.44% in 
spinner cells (3D-Myo-D14) and 4.67% in T-flask 
culture (2D-Myo-D14) as shown in Figure 4C. 
Moreover, expression of myogenin marker of my-
ogenic cells cycle exit (MYOG) was augmented 
Figure 1. Diagram presenting tested systems of in vitro 
cultures for (i) 2D-Myo-D0 (starting cell population),  
(ii) 2D-Myo-D14 (cell population obtained after 14 days  
of standard T-flask culture), and (iii) 3D-Myo-D14 (cell 
population obtained after 14 days of microcarrier culture).
Figure 2. The starting population of myoblast (2D-Myo-D0) in respect to standard myogenic markers. A. Immunocyto-
chemical staining for desmin (red). Nuclei counterstained with hematoxilin (blue); scale bar — 20 µm; B. Flow cytometry 
analysis of CD56 antigen expression on human myoblasts (2D-Myo-D0). Isotype control in black; anti-CD56 in blue.
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during longer period of in vitro culture (Figure 4D: 
2D-Myo-D0 vs. 2D-Myo-D14, p < 0.01; 2D-Myo-D0 
vs. 3D-Myo-D14, p < 0.001). We also observed that 
cells cultured on microcarriers showed higher ex-
pression of MYOG (2D-Myo-D14 vs. 3D-Myo-D14, 
p < 0.05).
As illustrated in Figure 5A in both culture systems, 
the cells were found positive for the b-galactosidase-SA. 
Figure 3. Microcarrier based in vitro culture system is less efficient in supporting cell proliferation compared to T-flask 
system. A. Myoblast samples after 4 h, 24 h, 48 h, 72 h, 96 h and 192 h of incubation on dextran microcarriers (Cytodex3®). 
Scale bars — 150 µm; B. Cells numbers during in vitro propagation in T-flask (2D-Myo-D14) and spinner (3D-Myo-D14) 
cultures.
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However, in myoblasts cultured in the cell spinner 
(3D-Myo-D14) differences were more significantly 
expressed; negatively-stained cell population was di-
minished while strongly-positive (aged) cells appeared 
(3D-Myo-D14 vs. 2D-Myo-D14 at p < 0.0001).
The presence of apoptotic cells was assessed 
using FITC-Annexin and Propidium Iodide (PI) 
staining followed by flow cytometry evaluation 
(Figure 5B). Reduced viable cell numbers in the 
populations tested vs. starting cell population 
(2D-Myo-D0) were observed (2D-Myo-D0 — 99.4%, 
2D-Myo-D14 — 88.4% and 3D-Myo-D14 — 69.7%) 
showing significant differences (p < 0.0001). 
Significant numbers of dead cells were visible in 
3D-Myo-D14 system in comparison to standard 
T-flask culture (p < 0.01).
Figure 4. Comparison of proliferation potential of myoblasts cultured in vitro on dextran microcarriers (3D-Myo-D14) 
and monolayer based T-flask (2D-Myo-D14) to starting cell population (2D-Myo-D0). A. Flow cytometry evaluation of 
the cell cycle distribution within analyzed myoblast populations (3D-Myo-D14 vs. 2D-Myo-D0, p < 0.0001); B. South-
ern blot analysis of myoblasts telomere length on d0 and after 14 days in both system of in vitro culture (2D-Myo-D0, 
p < 0.001); C1. Ki67 (proliferation marker) and H2A.X (DNA damage marker/double strand break) immunofluores-
cence evaluation; C2. Immunofluorescence staining of Ki67 (red) and H2A.X (green) in myoblast starting population 
(2D-Myo-D0), counterstained with DAPI (blue). Scale bar — 10 µm; D. Myogenin expression after long term in vitro 
myoblast culture in both culture systems in comparison to starting myoblast population (p < 0.001).
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The aim of this study was to evaluate a scaling up 
process efficacy of primary myoblast cultures com-
paring traditional (T-flasks) means of monolayer in 
vitro culture and in parallel studied collagen-coat-
ed-dextran microcarriers with concomitant spinning 
(bioreactor). This 3D-suspension in vitro culture 
attempt could potentially enable to procure large 
cell numbers lowering culture costs in opposition 
to standard T-flask-based laborious procedure. So 
far, myoblast microcarrier cultures were performed 
solely using established mouse cell lines (C2C12) or 
by using human myoblasts obtained from the young 
individual [10, 16]. High proliferative potential of 
mouse C2C12 cell line is widely recognized and un-
Figure 5. Apoptosis and cell senescence evaluation in myoblast populations under study. A. SA-b-galactosidase (SA-b-Gal) 
expression in tested in vitro culture system. Three distinct populations were clearly seen: negative for SA-b-Gal cells (I), 
moderately stained (II) and strongly stained cells (III); scale bar — 20 µm; B. Viable and apoptotic cells numbers in both 
culture systems were compared (2D-Myo-D0 vs. 2D-Myo-D14, p < 0.001, and 2D-Myo-D0 vs. 3D-Myo-D14, p < 0.0001). 
Dead cells population in 3D-Myo-D14 reached over 20% and was significantly higher than in the other analyzed myoblast 
populations.
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fortunately it is not comparable with human primary 
myoblast suspension characteristics, therefore in 
many cases it should not be used as a model relevant 
for primary human myoblasts. Moreover, it is known 
that human myoblast proliferative potential signifi-
cantly decreases with age [17]. The individual’s age 
seems to be the key factor for patient to whom stem 
cell therapy is proposed. In our experiments the cells 
obtained from adult donors in the Cytodex3® based 
in vitro culture failed to sustain an active proliferation 
in relation to the standard T-flask conditions. The 
reasons could be found in both the greater sensitivity 
of adult cells to shear forces operations in the stirring 
process or/and reduced the strength of myoblasts 
adhesion to the dextran microcarriers comparing to 
T-flask surface [14]. In previous experiments there 
was described the phenomenon of log-phase entering 
during myoblast microcarriers cultures [10]. It could 
cause the inhibition of cell proliferation for the first 
10 days of culture and only after this time point one 
could have noticed an increase in the cell number. 
However, in those experiments myoblasts derived 
originated from a very young donor and according 
to our group long-term observations (over 15 years) 
the patient age has a strong influence on the quantity 
and quality of myoblasts obtained (data not shown). It 
could be speculated that the infant-derived cells were 
able to adapt to microcarriers culture conditions on 
the contrary to the cells isolated from adult muscle 
tissue. Moreover, previous studies did not assess cell 
characteristics in detail (i.e. apoptotic or senescence 
cell markers etc.). 
In respect to myoblasts telomeres shortening data 
their length was not related to the culture system here 
applied. It has been previously demonstrated that 
myogenic cell line of immortalized mouse myoblasts 
(C2C12) showed some telomerase activity [18], while 
mouse satellite cells were telomerase positive only in 
in vivo conditions. However, human myoblasts lost 
their telomerase activity in in vitro culture within 
a few days [16]. It is likely to be a result of accelerated 
cell differentiation rather than the cell senescence [19]. 
Optimizing the conditions of human myoblast iso-
lation and in vitro culture for regenerative medicine 
purpose it could be beneficial not only to obtain cell 
populations with high telomerase activity, but one 
can consider to deliver signals for augmentation of 
telomerase expression until the requested numbers 
of cells are achieved. However, the oncogenic po-
tential of cells with high telomerase activity should 
be also considered. A change of the culture con-
ditions to diminish telomerase activity before cell 
transplantation could be therefore recommended. 
Replicative cell aging is described in the literature as 
state, where cells enter G0 phase, cease proliferation 
and exhibit number of changes in gene expression 
profile, morphology or cytophysiology. In agreement 
with previously obtained data, we have also observed 
a decreased number of myoblasts in in vitro culture 
presenting Ki67 proliferation marker. This may in-
dicate acceleration in reaching the Hayflick limit of 
cell population doubling while maintaining them on 
microcarriers with declining proliferative potential 
together and advanced replicative aging [20]. Evalua-
tion of myogenin expression determined by real-time 
PCR confirmed the results previously obtained in 
which the Northern Blot technique was used. Present 
study showed a significant increase in MYOG expres-
sion during in vitro culture of cells on microcarriers 
(3D-Myo-D14). This confirms the observation that 
long-term culture of human myoblasts does not lead 
to the loss of their myogenic potential but it seems that 
the cells go through successive stages of differentia-
tion during extended in vitro propagation. Moreover, 
the myogenin expression has been also discussed as 
a first marker towards establishment of post mitotic 
state of differentiating myoblasts [21]. Some authors 
indicate that mechanical stimulation via laminin 
receptors leads to increase of myogenin expression 
and induces myotube formation. In our experiments, 
Cytodex®3 anchored cells experienced much stronger 
mechanical stress due to beads binding and medium 
stirring so upregulation of myogenin expression could 
have occurred [22]. The presence of b-galactosidase 
enzyme (SA-beta-Gal) could be correlated with the 
cells senescence status in in vitro culture [23]. Also in 
this case, the conditions provided by standard T-flask 
culture were more favourable than those in the cell 
spinner system. 
The hostile culture environment of spinner caused 
further reduction of cell viability with significantly 
increasing population of dead cells. Application of 
stirring cycles can hamper cell adhesion and shear 
forces could have also led to the observed cell loss. 
Incidentally, culture conditions favouring the replica-
tive aging do not seem to be beneficial and justified 
for stem cell propagation. Myoblast cell therapy can 
be also potentially offered to dystrophic patients. 
It is well documented that muscular dystrophies 
are frequently linked to premature cell aging and 
exhaustion of satellite cells pool [24] so dystrophic 
myoblasts obtained from relatively young individuals 
should be considered as the adult ones demonstrating 
of diminished proliferative potential.
The present study shows that despite the encourag-
ing results of in vitro bioreactor approach pursued by 
the other research groups employing either the mouse 
myoblast immortalized C2C12 line or infant-derived 
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human primary myoblast population, adult human 
skeletal myoblasts microcarrier culture exhibited a 
number of serious disadvantages. Therefore, we tend 
to think that this is the first report describing the 
impact of spinner 3D-type of culture conditions on 
adult human myoblast viability.
Faster replicative aging and reduced number of 
proliferating cells raise the doubts in applicability of 
this cell culture system for myogenic origin stem cells. 
Because myoblasts are extraordinary promising as a 
source of cells in their potential application in re-
generative medicine there should be further pursued 
continuing efforts towards the optimization of culture 
medium and/or its supplements. Since the main goal 
is to create the conditions similar to the satellite cells 
niche in vivo in order to support telomerase activity 
thus obtaining the cell population with increased 
proliferative potential would be desired. 
Since the negative effect of the cell spinner in vitro 
culture has been shown here on adult primary human 
myoblast suspensions one could speculate the reason 
for such phenomenon. It should be indicated both 
shear forces and possibly mechanical stress could 
be one of the considerable reasons. There is still 
a strong need to create a new platform devoid of these 
setbacks; however, the putative new systems should 
also offer a more favourable free surface to culture 
medium volume ratio in respect to dextran micro-
carriers. It appears to be feasible that treatment with 
adhesively-dependent stem cells should be introduced 
as the standard procedure directed to a large number 
of patients.
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